No new purchase or sale is warranted. Hold AAPL and the broader core portfolio, preserve the 27.8% cash reserve, avoid averaging down in HD, GOOGL, AMZN, or UNH, and wait for improved breadth or clearer stabilization before deploying capital.
No trades this day. The fund held.
A directional call (beat or lag the S&P 500 over the horizon) on every researched name, whether or not the fund traded it. 34 calls (19 outperform, 15 underperform); 0 became trades. These are the fund's calibration record.
| Symbol | Call | Conf. | Why | |
|---|---|---|---|---|
| HD | Underperform SPY | 71% | HD's 10.5% 30-day decline and continued five-day weakness make it the clearest current holding likely to lag SPY. | |
| META | Outperform SPY | 70% | META's 7.0% five-day and 10.8% 30-day gains are the strongest relative-strength signal among current large-cap holdings. | |
| CORZ | Underperform SPY | 69% | The 14.1% 30-day decline is severe relative underperformance and the small five-day gain does not confirm a reversal. | |
| AMZN | Underperform SPY | 68% | The 7.3% 30-day decline and recent negative momentum lag the benchmark, with data-center tax-break concerns adding uncertainty. | |
| GOOGL | Underperform SPY | 68% | Negative five-day and 7.5% 30-day returns, combined with AI-competitive concerns, indicate continued relative weakness. | |
| AVGO | Underperform SPY | 67% | The 13.4% 30-day decline is materially worse than SPY despite a modest recent rebound. | |
| MU | Outperform SPY | 67% | Memory-sector momentum is strong, with 7.3% five-day and 16.6% 30-day gains ahead of a cited earnings catalyst. | |
| GLW | Outperform SPY | 66% | The Verizon fiber agreement news and strong 15.4% five-day and 7.4% 30-day returns support continued relative strength. | |
| BE | Outperform SPY | 65% | Strong 14.3% five-day and 17.6% 30-day gains signal powerful relative momentum, albeit with elevated volatility risk. | |
| ORCL | Outperform SPY | 65% | Positive five-day and 12.7% 30-day gains indicate favorable relative cloud and AI momentum. | |
| INTC | Outperform SPY | 64% | The 15.9% five-day and 6.4% 30-day gains show strong relative momentum versus SPY. | |
| AMD | Outperform SPY | 63% | AMD's 14.2% five-day and 6.5% 30-day gains indicate strong relative momentum versus SPY. | |
| XOM | Outperform SPY | 63% | Oil above $100 and XOM's positive five-day and 6.8% 30-day performance support relative strength. | |
| CRWV | Outperform SPY | 62% | Double-digit gains over both five and 30 days support relative strength, though company-specific volatility remains high. | |
| IREN | Outperform SPY | 61% | Strong five-day and 30-day gains, supported by AI-infrastructure interest, favor outperformance but with high volatility. | |
| SNDK | Outperform SPY | 61% | Exceptional 30-day momentum supports outperformance, though the reported same-day slump makes the setup volatile and extended. | |
| UNH | Underperform SPY | 61% | Negative five-day and 30-day momentum, with no confirmed positive catalyst, favor continued lagging performance. | |
| JNJ | Outperform SPY | 60% | JNJ's positive 30-day return and defensive profile favor relative resilience despite its recent 4.1% pullback. | |
| TSM | Outperform SPY | 60% | Positive returns over both five and 30 days support moderate semiconductor relative strength. | |
| WMT | Underperform SPY | 60% | The 5.3% 30-day decline and negative five-day return point to relative weakness. | |
| ASML | Outperform SPY | 59% | Positive five-day and 30-day returns provide a moderately constructive relative-momentum profile. | |
| ^VIX | Outperform SPY | 59% | Rising yields, oil-price pressure, and correction concerns favor elevated volatility relative to SPY. | |
| APLD | Underperform SPY | 58% | A 6.0% 30-day decline outweighs the recent five-day bounce and leaves the relative trend unconfirmed. | |
| NVDA | Outperform SPY | 57% | A positive 30-day return versus a declining SPY supports modest outperformance, though recent weakness and AI-capex sensitivity constrain confidence. | |
| AAPL | Outperform SPY | 56% | Positive 30-day return against a declining SPY supports modest relative outperformance, though recent product-cycle weakness limits conviction. | |
| PG | Underperform SPY | 56% | Negative returns over both five and 30 days point to a weak relative trend despite defensive characteristics. | |
| TSLA | Outperform SPY | 56% | The strong 15.1% 30-day gain supports relative outperformance despite a negative recent five-day move. | |
| CAT | Underperform SPY | 55% | A negative 30-day return and only modest recent strength leave CAT's trend weaker than the preferred relative-momentum profile. | |
| MSFT | Underperform SPY | 55% | Negative five-day and 30-day returns and capex-related skepticism modestly favor underperformance despite a strong gain versus cost. | |
| MA | Underperform SPY | 54% | Negative five-day and 30-day momentum marginally favors lagging SPY despite substantial gains versus portfolio cost. | |
| V | Underperform SPY | 54% | Negative returns over both reported periods slightly favor underperformance despite the position's strong gain versus cost. | |
| JPM | Underperform SPY | 53% | Slightly negative five-day and 30-day returns suggest modest lagging performance as higher yields create a mixed macro backdrop. | |
| QQQ | Outperform SPY | 51% | QQQ's near-flat 30-day result is slightly better than SPY, but the advantage is too small for high conviction. | |
| SPY | Underperform SPY | 50% | SPY is the comparison benchmark; risk-off macro conditions leave the broad-market direction uncertain, so this is a neutral reference call. |
The strongest buy-and-hold case is to maintain exposure to the portfolio's relative-strength leaders rather than react to a broad, risk-off pullback. The S&P 500 is down 1.2% over 30 days, yet several holdings remain positive and materially outperforming: META is up 10.8%, JNJ 4.4%, NVDA 2.1%, and AAPL 1.0%. These leaders are supported by identifiable catalysts, while the portfolio also retains approximately $287,000 in cash to manage volatility. The evidence favors holding winners and selectively adding to strength, not wholesale de-risking.
The portfolio is exposed to broad and worsening downside momentum, with the clearest weakness concentrated in several current holdings and candidates. HD, GOOGL, and UNH are already below cost, while AMZN, GOOGL, and HD have especially poor 30-day performance. The weakness is not isolated: MSFT, JPM, MA, V, and UNH are also fading, and multiple candidates show even sharper declines. With the S&P 500 down 1.19% over 30 days, the evidence favors caution rather than adding to these exposures until momentum stabilizes.
The biggest capital risk is concentration: 71.0% of invested assets is held in AAPL, AMZN, and JNJ, while 90.1% of invested assets is concentrated in Information Technology, Consumer Discretionary, and Health Care. Cash at 27.8% materially reduces portfolio-level exposure and provides a buffer, but it does not diversify the invested sleeve.
Cash is 27.8% of portfolio value, above the 25% threshold, and is intentional rather than idle. It cushions the portfolio against a potentially yield- and oil-driven correction, offsets concentrated equity exposure, and preserves optionality for purchases only after broader market stabilization or confirmed company-specific strength. Deploying cash now would increase risk into weak breadth while the portfolio already has large AAPL, AMZN, JNJ, and technology exposures.
Accept: HD is the clearest deterioration case, being below cost and down 10.5% over 30 days; no addition is justified. Accept: GOOGL is below cost and down 7.5% over 30 days, and AMZN is down 7.3%; neither should receive new capital before stabilization. Accept: UNH is below cost with negative short- and medium-term momentum, so its small position should simply be monitored. Accept: negative 30-day returns in MSFT, JPM, MA, and V show that weakness extends beyond the losing positions, although their gains versus cost and generally modest portfolio weights do not warrant reactive sales. Accept: weak watchlist momentum in AVGO, CORZ, APLD, CAT, WMT, and PG is unsuitable for new purchases. Partially reject: broad market weakness alone does not require liquidating profitable core positions. JNJ, AAPL, NVDA, and especially META retain relative-strength evidence versus the declining benchmark, and the 27.8% cash reserve permits patience. The appropriate synthesis is hold existing sized exposure, avoid averaging down, avoid new risk, and reassess only if deterioration persists or concentration becomes more acute.
The market backdrop is risk-off: SPY is down 0.8% over 30 days, the S&P 500 benchmark is down 1.19%, VIX is up 8.6% over 30 days, and news cites rising yields, oil above $100, and renewed correction concerns. Breadth is uneven, with several AI, memory, infrastructure, and semiconductor names showing strong momentum while many large-cap portfolio holdings have weakened recently. This is not a favorable setup for broad cash deployment.
Maintain the existing core positions without new purchases or broad selling. The portfolio has meaningful unrealized gains in JNJ, AAPL, MSFT, NVDA, payments, and META, while HD and GOOGL are below cost and AMZN has notably weak 30-day momentum. The principal issue remains concentration: AAPL, AMZN, and JNJ dominate the invested sleeve. Recent fund memory supports low turnover, selective rather than reactive trimming, and avoiding additional exposure to concentrated technology and consumer-discretionary positions. Memory references: risk_lesson:run_20260803T191113Z_b5f11a59:report_risk, risk_lesson:run_20260729T184341Z_54100baf:report_risk, report_summary:run_20260826T160411Z_f30a1737.
The major risk is concentration rather than lack of liquidity. AAPL, AMZN, and JNJ represent roughly 71% of invested assets, while technology, consumer discretionary, and health care dominate the equity sleeve. AAPL, AMZN, GOOGL, MSFT, and NVDA also create correlated AI, cloud, consumer-device, and regulatory exposure. HD is down 10.5% over 30 days and GOOGL down 7.5%, making them the clearest weak holdings; AMZN's 7.3% 30-day decline also warrants monitoring. Retaining cash reduces total-portfolio beta, but it does not resolve the concentration inside invested assets.